J&J’s Covid-19 booster shot offers greater antibody responses
J&J’s booster given after Pfizer-BioNTech’s two-dose regimen led to a continued rise of antibodies for a minimum of four weeks.
Israel
Latest in
Israel
RedHill reports data from Covid-19 clinical trial of opaganib
The data showed 62% statistically significant reduction in mortality and 21% efficacy benefit with opaganib.
Israel observes record high in Covid-19 cases in September despite mass vaccination
Understanding the sudden increase in confirmed Covid-19 cases in Israel will help contain the virus and avoid a fourth lockdown.
By
Enlivex to commence Phase IIb trial of cell therapy for Covid-19 ARDS
The trial will assess the safety and efficacy of Allocetra given along with the standard of care in a total…
Oravax to commence trials of oral Covid-19 vaccine in Israel
The VLP vaccine addresses three surface proteins of SARS CoV-2, which could allow its efficacy against viral variants.
MGC Pharma starts enrolment in Phase III Covid-19 trial of CimetrA
The data from the Phase III trial is anticipated to allow future trials of the therapeutic for treating Covid-19 patients.
SciSparc to trial cannabinoid candidate for Alzheimer’s
The primary goals of the trial are the drug’s safety and ability to address behavioural disturbances in Alzheimer's patients.
RedHill concludes enrolment in Phase II/III Covid-19 drug trial
The trial’s primary endpoint is the proportion of participants not requiring oxygen support by day 14.